PT  - JOURNAL ARTICLE
AU  - Alayche, Mohsen
AU  - Cobey, Kelly D.
AU  - Ng, Jeremy Y.
AU  - Ardern, Clare L.
AU  - Khan, Karim M.
AU  - Chan, An-Wen
AU  - Chow, Ryan
AU  - Masalkhi, Mouayad
AU  - Ayala, Ana Patricia
AU  - Ebrahimzadeh, Sanam
AU  - Ghossein, Jason
AU  - Alayche, Ibrahim
AU  - Willis, Jessie V.
AU  - Moher, David
TI  - Evaluating prospective study registration and result reporting of trials conducted in Canada from 2009-2019
AID  - 10.1101/2022.09.01.22279512
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.09.01.22279512
4099  - http://medrxiv.org/content/early/2022/09/02/2022.09.01.22279512.short
4100  - http://medrxiv.org/content/early/2022/09/02/2022.09.01.22279512.full
AB  - Background Adherence to study registration and reporting best practices are vital to foster evidence-based medicine. Poor adherence to these standards in clinical trials conducted in Canada would be detrimental to patients, researchers, and the public alike.Methods All registered clinical trials on ClinicalTrials.gov conducted in Canada as of 2009 and completed by 2019 were identified. A cross-sectional analysis of those trials assessed prospective registration, subsequent result reporting in the registry, and subsequent publication of study findings. The lead sponsor, phase of study, clinical trial site location, total patient enrollment, number of arms, type of masking, type of allocation, year of completion, and patient demographics were examined as potential effect modifiers to these best practices.Results A total of 6,720 trials met the inclusion criteria. From 2009-2019, 59% (n=3,967) of them were registered prospectively and 39% (n=2,642) reported their results in the registry. Of the trials registered between 2009-2014, 55% (n=1,482) were subsequently published in an academic journal. Of the 3,763 trials conducted exclusively in Canada, 3% (n=123) met all 3 criteria of: prospective registration, reporting in the registry, and publishing findings. In contrast, of the remaining 2,957 trials with both Canadian and international sites, 41% (n=1,238) had an overall compliance to these three criteria. Overall, the odds of having adherence to all three practices concurrently in Canadian trials decreases by 95% when compared to international trials (OR = 0.05; 95CI: 0.04 – 0.06).Conclusion Canadian clinical trials substantially lacked adherence to study registration and reporting best practices. Knowledge of this widespread non-compliance should motivate stakeholders in the Canadian clinical trials ecosystem to address and continue to monitor this problem. The data presented provides a baseline against which to compare any improvement in the registration and reporting of clinical trials in Canada.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://osf.io/kb4nf/ Funding StatementThis work was funded by the Summer Studentship Program from the University of Ottawa, Faculty of Medicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available online at https://osf.io/kb4nf/ https://osf.io/kb4nf/